CLDX - celldex.com Market Capitalization
This daily price chart for Celldex Therapeutics (CLDX), with a market capitalization fixed at 2.40, reflects the quotes of the immune therapy developer. Geopolitical instability and sanctions are currently hindering cross-border testing and the logistics of biological products. Expectations for urticaria therapy are already priced in, while new growth triggers are linked to the launch of final-stage trials. Investors are relying on the company's high scientific standing in the development of cancer antibodies.
Comprehensive metric breakdowns and analytics for Celldex Corp (CLDX)
- market price and analyst price targets:
- market capitalization statistics:
- issuer book value statistics:
- company total debt and liquidity indicators:
Total Debt to Capital Celldex Therapeutics|CLDX - Long-Term Debt to Capital Coefficient|Short-Term Debt to Capital Celldex Therapeutics|CLDX - Company Aggregate Debts|Debt to Book Capitalization Ratio Celldex Corp|CLDX - Company Long-Term Loans and Borrowings|Company Short-Term Debt Celldex Therapeutics|Quick Ratio celldex.com
- net income and valuation multiples indicators:
CLDX - Net Profit|Future Profit Celldex Therapeutics|CLDX - Company Value to Net Income|Forward P/E Multiple Celldex|CLDX - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Celldex Corp|CLDX - Operating profit before deduction of amortization|Earnings per share for the last twelve months Celldex Therapeutics|CLDX - Net earnings per share for the last 12 months|Year-over-year net earnings per share growth for the last 12 months celldex.com|CLDX - Earnings growth in current year|Net earnings per share growth forecast for next year Celldex Therapeutics
Fundamental company analysis:CLDX (Celldex Therapeutics, Inc.)
Celldex Therapeutics (CLDX) is positioned as a resilient defensive asset due to its insulation from macroeconomic shocks driven by demand for unique drugs. The total equity value, reflected in the issuer's current market valuation, serves as the basis for liquidity stress testing and determining the capital safety margin, allowing investors to promptly identify overvaluation risks or signs of financial exhaustion within the company.
Key competitors
Market Value argenx ARGX|BioNTech Inc. - Market Value|Abivax S.A. - Market Capitalization|ADMA (ADMA Corp) - Market Capitalization|PTGX (Protagonist Therapeutics) - Market Valuation|Market Capitalization IMVT|Market Value Kiniksa|Grifols SA - Market Valuation|Market Capitalization ADPT|AUPH (Aurinia Corp) - Market Value|Market Capitalization BCRX (BioCryst)|Market Capitalization veratx.com VERA|DNTH - Market Value|Market Value PHVS (Pharvaris NV)|AbCellera (ABCL) - Market Value|Market Valuation Tourmaline|PGEN (Precigen, Inc.) - Market Capitalization|Market Capitalization pharming.com|Market Valuation NKTR (Nektar Therapeutics Inc.)|UPB (Upstream Bio, Inc.) - Market Value|Market Capitalization ZBIO (Zenas Biopharma, Inc.)|Market Capitalization Immunome Bio (IMNM)|GOSS - Market Value|kalvista.com (KALV) - Market Valuation|Septerna (SEPN) - Market Value|Market Valuation Pieris Pharma|Market Valuation SVRA|Market Capitalization Rigel Corp|Market Value AnaptysBio, Inc. (ANAB)|astriatx.com - Market Capitalization|Market Capitalization ENGN (enGene)|rapt.com (RAPT) - Market Value|Aerovate - Market Capitalization|Aclaris Therapeutics, Inc (ACRS) - Market Valuation|KYTX: Market Capitalization|Market Value tizianalifesciences.com (TLSA)|Market Value Cabaletta Bio|Market Value VTYX|Market Value Theratechnologies Inc (THTX)|Market Value AVTX (Avalo Therapeutics Inc)|Market Capitalization ELDN (Eledon Pharmaceuticals)|AGEN: Market Capitalization|Climb Bio - Market Capitalization|Market Value zurabio.com|ATYR (aTyr) - Market Valuation|Market Capitalization ADAG|Market Valuation IMA|STTK: Market Value|Market Valuation EQ (Equillium, Inc.)|Market Value CNTB|Market Capitalization IMUX (Immunic)|Market Value ATRA|InflaRx GmbH - Market Capitalization|Market Value x4pharma.com|adicetbio.com (ACET) - Market Value|Celularity - Market Value|INMB (INmune Bio Corp) - Market Capitalization|Market Capitalization Barinthus Biotherapeutics Corp|Market Value Kezar Life Sciences (KZR)|SABS: Market Valuation|Market Capitalization AKTX (Akari Therapeutics Plc)|Enlivex Therapeutics Ltd (ENLV) - Market Value|QTTB: Market Valuation|GOVX - Market Capitalization|EDSA (Edesa Biotech, Inc.) - Market Valuation|IBIO: Market Value|CARM (Carisma Therapeutics Inc) - Market Capitalization|XTL Biopharmaceuticals Ltd (XTLB) - Market Capitalization|Market Capitalization BOLT|Market Valuation hcwbiologics.com HCWB|Market Value Aptevo Therapeutics Inc. APVO|Market Capitalization aimimmuno.com (AIM)|Aditxt Corp - Market Capitalization|GRI Bio Inc (GRI) - Market Valuation|XORTX (XRTX) - Market Value|HIND (Vyome Therapeutics) - Market Value|REVB (Revelation Biosciences) - Market Capitalization|Market Capitalization INDP (indaptusrx.com)|Market Valuation SCNI (Scinai Immunotherapeutics Ltd.)|calcimedica.com - Market Capitalization|Market Value Affimed N.V. AFMD|ALLK (Allakos Inc) - Market Valuation|HOOKIPA - Market Capitalization|Market Value IGMS (IGM Biosciences, Inc.)|ITOS: Market Capitalization|Ocean Biomedical Inc (OCEA) - Market Capitalization|Market Value TC BioPharm (Holdings) PLC|THRD: Market Value
